- Home
- CRVS vs JACK Comparison
CRVS vs JACK Comparison
Compare CRVS & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- JACK
- Stock Information
- Founded
- CRVS 2014
- JACK 1951
- Country
- CRVS United States
- JACK United States
- Employees
- CRVS N/A
- JACK N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- JACK Restaurants
- Sector
- CRVS Health Care
- JACK Consumer Discretionary
- Exchange
- CRVS Nasdaq
- JACK Nasdaq
- Market Cap
- CRVS 459.0M
- JACK 382.0M
- IPO Year
- CRVS 2016
- JACK 1987
- Fundamental
- Price
- CRVS $8.04
- JACK $16.04
- Analyst Decision
- CRVS Strong Buy
- JACK Hold
- Analyst Count
- CRVS 4
- JACK 17
- Target Price
- CRVS $13.75
- JACK $30.13
- AVG Volume (30 Days)
- CRVS 1.1M
- JACK 1.2M
- Earning Date
- CRVS 11-04-2025
- JACK 11-19-2025
- Dividend Yield
- CRVS N/A
- JACK 5.49%
- EPS Growth
- CRVS N/A
- JACK N/A
- EPS
- CRVS N/A
- JACK N/A
- Revenue
- CRVS N/A
- JACK $1,488,411,000.00
- Revenue This Year
- CRVS N/A
- JACK N/A
- Revenue Next Year
- CRVS N/A
- JACK N/A
- P/E Ratio
- CRVS N/A
- JACK N/A
- Revenue Growth
- CRVS N/A
- JACK N/A
- 52 Week Low
- CRVS $2.54
- JACK $14.88
- 52 Week High
- CRVS $10.00
- JACK $54.42
- Technical
- Relative Strength Index (RSI)
- CRVS 64.17
- JACK 38.92
- Support Level
- CRVS $7.46
- JACK $17.12
- Resistance Level
- CRVS $7.96
- JACK $18.55
- Average True Range (ATR)
- CRVS 0.56
- JACK 1.07
- MACD
- CRVS 0.01
- JACK -0.23
- Stochastic Oscillator
- CRVS 75.46
- JACK 19.74
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About JACK Jack In The Box Inc.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.